BWD

BWD is a PSMA ligand (IC50 = 35.86) . BWD exhibits excellent in vitro stability and high affinity. BWD can enhance tumor uptake and retention. BWD can inhibit tumor growth in vivo. BWD can be studied in anticancer research[1].

Product Specifications

UNSPSC

12352005

Target

PSMA

Related Pathways

Immunology/Inflammation

Field of Research

Cancer

Smiles

CC1=CC=C(C=C1)CCCC(N[C@@H](C(NCCCCCN(C(C2C3=C(C4=C2C=CC=C4)C=CC=C3)=O)CCCC[C@@H](C(O)=O)NC(N[C@H](CCC(O)=O)C(O)=O)=O)=O)CCCCNC(CN(CCN(CC5)CC(O)=O)CCN(CCN5CC(O)=O)CC(O)=O)=O)=O

Molecular Formula

C64H90N10O17

Molecular Weight

1271.46

References & Citations

[1]Yang Liu, et al., (2025) . In Vitro and In Vivo Study of Novel PSMA-Targeted Radioligands: Enhancing Tumor Uptake and Therapeutic Efficacy through Zwitterionization and Albumin-Binding Strategies. Mol. Pharmaceutics 2025, 22, 7, 3961–3975.